- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07699822
Myofascial Line Training Effects on Mobility and Endurance in Adolescent Football Players
July 7, 2026 updated by: Inci Kesilmis, Mersin University
Effects of Posterior vs. Spiral Myofascial Line Training on Joint Mobility and Myofascial Isometric Endurance in Adolescent Football Players: A Randomized Crossover Trial
This study compared the effects of two myofascial chain training programs - the Superficial Posterior Line (PL) and the Spiral Line (SL) - on joint mobility and myofascial isometric endurance in adolescent male football players.
Thirty-eight licensed male players (ages 15-16) were enrolled in a randomized crossover trial consisting of two 6-week training phases (12 weeks total), with follow-up measurements at week 16.
Each program was delivered twice weekly in 30-minute sessions alongside regular club training.
Joint mobility was assessed using goniometry (shoulder flexion, hip flexion, hip extension, popliteal angle), and myofascial isometric endurance was evaluated using the Bunkie Test across five lines (APL, PPL, PSL, LSL, MSL).
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mersin
-
Mersin, Mersin, Turkey (Türkiye), 33343
- Mersin University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male, aged 15-16 years (U15-U16 category)
- Holding an active football player license and currently competing with a club team
- Regularly participating in routine club training sessions
- Free from any injury or musculoskeletal condition that could affect -performance testing at the time of enrollment
- Parental/legal guardian consent and participant assent obtained
Exclusion Criteria:
- Presence of any musculoskeletal injury, recent surgery, or medical condition affecting lower-limb function within the past 6 months
- Inability to attend the required training sessions or assessment time points
- Unwillingness or inability of parents/legal guardians to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PL-First Group (PLFG)
Participants first completed 6 weeks of Superficial Posterior Line (PL) myofascial training, followed by 6 weeks of Spiral Line (SL) myofascial training.
|
6-week myofascial training program targeting the posterior chain (plantar fascia, gastrocnemius, hamstrings, erector spinae).
Two 30-minute sessions per week.
6-week myofascial training program targeting the spiral chain (rhomboids, serratus anterior, obliques, ITB, fibularis longus).
Two 30-minute sessions per week.
|
|
Experimental: SL-First Group (SLFG)
Participants first completed 6 weeks of Spiral Line (SL) myofascial training, followed by 6 weeks of Superficial Posterior Line (PL) myofascial training.
|
6-week myofascial training program targeting the posterior chain (plantar fascia, gastrocnemius, hamstrings, erector spinae).
Two 30-minute sessions per week.
6-week myofascial training program targeting the spiral chain (rhomboids, serratus anterior, obliques, ITB, fibularis longus).
Two 30-minute sessions per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myofascial Isometric Endurance (Bunkie Test)
Time Frame: Baseline, Week 6, Week 12, and Week 16
|
Isometric endurance of five myofascial lines (APL, PPL, PSL, LSL, MSL) assessed in seconds using the Bunkie Test protocol.
|
Baseline, Week 6, Week 12, and Week 16
|
|
Shoulder Flexion Range of Motion
Time Frame: Baseline, Week 6, Week 12, and Week 16
|
degrees
|
Baseline, Week 6, Week 12, and Week 16
|
|
Hip Flexion Range of Motion
Time Frame: Baseline, Week 6, Week 12, and Week 16
|
degrees
|
Baseline, Week 6, Week 12, and Week 16
|
|
Hip Extension Range of Motion
Time Frame: Baseline, Week 6, Week 12, and Week 16
|
degrees
|
Baseline, Week 6, Week 12, and Week 16
|
|
Popliteal Angle
Time Frame: Baseline, Week 6, Week 12, and Week 16
|
degrees
|
Baseline, Week 6, Week 12, and Week 16
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 5, 2025
Primary Completion (Actual)
September 1, 2025
Study Completion (Actual)
December 22, 2025
Study Registration Dates
First Submitted
June 25, 2026
First Submitted That Met QC Criteria
July 7, 2026
First Posted (Actual)
July 13, 2026
Study Record Updates
Last Update Posted (Actual)
July 13, 2026
Last Update Submitted That Met QC Criteria
July 7, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- MEU-SBF-IK-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Athletic Performance Enhancement
-
Coşkun YILMAZCompletedAthletic Performance | Neuromuscular Adaptations | Athletic Performance EnhancementTurkey (Türkiye)
-
Federal University of VicosaCompletedSprint Performance | Futsal | Jump Performance | Athletic Performance EnhancementColombia
-
Salih ÇABUKCompletedAnaerobic Performance | Athletic Performance Enhancement (Kickboxing) | Strength Endurance | Neuromuscular Power | Nutritional Supplementation (β-Alanine)Turkey (Türkiye)
-
Antonio Molina LopezUniversidad Europea de Madrid; Universidad Pablo de OlavideCompletedAthletic Performance Enhancement | Body Composition Optimization | Nutritional Supplementation in AthletesItaly
-
St. Mary's University, TwickenhamNot yet recruitingPerformance EnhancementUnited Kingdom
-
United States Army Aeromedical Research LaboratoryCompletedPerformance EnhancementUnited States
-
Elif TurgutHacettepe UniversityRecruitingShoulder | Athlete | Performance EnhancementTurkey (Türkiye)
-
Istanbul Topkapi UniversityCompletedCyclists | Performance Enhancement | Isokinetic TestTurkey (Türkiye)
-
Federal University of VicosaUniversidad de AntioquiaCompletedAthletic Performance | Exercise PerformanceColombia
Clinical Trials on Superficial Posterior Line (PL) Myofascial Training
-
Mersin UniversityCompletedAthletic PerformanceTurkey (Türkiye)